首页> 外文期刊>The lancet oncology >MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial
【24h】

MRI versus mammography for breast cancer screening in women with familial risk (FaMRIsc): a multicentre, randomised, controlled trial

机译:MRI与家族风险(FAMRISC)患有乳腺癌乳腺癌的MRI与乳腺X线摄影:多期,随机,受控试验

获取原文
获取原文并翻译 | 示例
           

摘要

Background Approximately 15% of all breast cancers occur in women with a family history of breast cancer, but for whom no causative hereditary gene mutation has been found. Screening guidelines for women with familial risk of breast cancer differ between countries. We did a randomised controlled trial (FaMRIsc) to compare MRI screening with mammography in women with familial risk.
机译:背景,患有乳腺癌家族史的女性中,大约15%的乳腺癌发生,但没有发现任何致病性遗传基因突变。 国家患有乳腺癌家族风险的妇女筛查指南。 我们做了一个随机对照试验(FAMRISC),以将MRI筛查与家族风险的妇女乳腺X线摄影进行比较。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号